Henry Schein, Inc. (HSIC) Analysts See $0.97 EPS; Last Week Yingli Green Energy Holding Company Limited (YGE) Analysts

February 15, 2018 - By Ellis Scott

Among 5 analysts covering Yingli Green Energy (NYSE:YGE), 0 have Buy rating, 4 Sell and 1 Hold. Therefore 0 are positive. Yingli Green Energy had 9 analyst reports since August 21, 2015 according to SRatingsIntel. The rating was upgraded by Axiom Capital on Thursday, October 6 to “Buy”. TH Capital downgraded the shares of YGE in report on Wednesday, September 9 to “Sell” rating. The company was downgraded on Wednesday, November 16 by Axiom Capital. As per Wednesday, December 20, the company rating was maintained by Roth Capital. The firm earned “Sell” rating on Wednesday, September 9 by Roth Capital. The company was maintained on Thursday, June 15 by Roth Capital. The stock of Yingli Green Energy Holding Company Limited (NYSE:YGE) has “Sector Perform” rating given on Wednesday, September 9 by RBC Capital Markets. The rating was initiated by Axiom Capital on Friday, August 21 with “Sell”. See Yingli Green Energy Holding Company Limited (NYSE:YGE) latest ratings:

20/12/2017 Broker: Roth Capital Rating: Sell New Target: $1.6 Maintain

Analysts expect Henry Schein, Inc. (NASDAQ:HSIC) to report $0.97 EPS on February, 20.They anticipate $0.03 EPS change or 3.19% from last quarter’s $0.94 EPS. HSIC’s profit would be $152.24 million giving it 17.64 P/E if the $0.97 EPS is correct. After having $0.87 EPS previously, Henry Schein, Inc.’s analysts see 11.49% EPS growth. The stock increased 1.54% or $1.04 during the last trading session, reaching $68.43. About 2.57 million shares traded or 25.06% up from the average. Henry Schein, Inc. (NASDAQ:HSIC) has risen 4.05% since February 15, 2017 and is uptrending. It has underperformed by 12.65% the S&P500.

The stock increased 5.26% or $0.08 during the last trading session, reaching $1.6. About 43,627 shares traded. Yingli Green Energy Holding Company Limited (NYSE:YGE) has declined 31.04% since February 15, 2017 and is downtrending. It has underperformed by 47.74% the S&P500.

Yingli Green Energy Holding Company Limited, together with its subsidiaries, designs, develops, makes, assembles, sells, and installs photovoltaic products. The company has market cap of $29.08 million. The firm offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects. It currently has negative earnings. It is also involved in import and export trading activities; and the provision of research and experimental development on electronics.

Investors sentiment increased to 7.15 in Q3 2017. Its up 5.99, from 1.16 in 2017Q2. It is positive, as 47 investors sold Henry Schein, Inc. shares while 15 reduced holdings. 66 funds opened positions while 377 raised stakes. 279.70 million shares or 306.41% more from 68.82 million shares in 2017Q2 were reported. 6,716 are owned by Capstone Invest Advsrs. Gulf Intll Bank (Uk) has 0.06% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 49,870 shares. The Tennessee-based Ftb Advsrs has invested 0.01% in Henry Schein, Inc. (NASDAQ:HSIC). Ami Asset reported 362,885 shares or 2.11% of all its holdings. Kentucky Retirement System stated it has 0.06% in Henry Schein, Inc. (NASDAQ:HSIC). The Texas-based Serv Automobile Association has invested 0.02% in Henry Schein, Inc. (NASDAQ:HSIC). Vanguard Group invested in 16.31M shares. First Interstate Retail Bank has 110 shares. Waratah Capital Advsr Ltd owns 15,000 shares. Commercial Bank Of Montreal Can stated it has 0.03% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Cubist Systematic Strategies Limited Co holds 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 11,596 shares. Cipher Cap Ltd Partnership has invested 0.02% in Henry Schein, Inc. (NASDAQ:HSIC). Mercer Cap Advisers Incorporated accumulated 300 shares. 183,211 are held by Hsbc Public Limited Com. 396 are owned by Advisory Serv Llc.

Henry Schein, Inc. provides health care services and products to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company has market cap of $10.74 billion. It operates through two divisions, Health Care Distribution, and Technology and Value-Added Services. It has a 19.68 P/E ratio. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

Among 19 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 11 have Buy rating, 1 Sell and 7 Hold. Therefore 58% are positive. Henry Schein Inc. had 43 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Henry Schein, Inc. (NASDAQ:HSIC) earned “Buy” rating by Robert W. Baird on Thursday, October 19. The firm has “Buy” rating given on Monday, September 12 by Bank of America. The stock of Henry Schein, Inc. (NASDAQ:HSIC) earned “Hold” rating by Stifel Nicolaus on Tuesday, August 8. The stock has “Buy” rating by UBS on Thursday, October 6. The stock has “Market Perform” rating by Leerink Swann on Tuesday, November 7. As per Tuesday, November 7, the company rating was maintained by Jefferies. The stock has “Buy” rating by Craig Hallum on Tuesday, November 7. The company was maintained on Wednesday, September 27 by Jefferies. Stifel Nicolaus maintained Henry Schein, Inc. (NASDAQ:HSIC) rating on Tuesday, November 7. Stifel Nicolaus has “Hold” rating and $77.0 target. The stock of Henry Schein, Inc. (NASDAQ:HSIC) earned “Buy” rating by Piper Jaffray on Thursday, October 26.

Since September 6, 2017, it had 0 buys, and 1 sale for $366,756 activity. Rose Paul sold $366,756 worth of Henry Schein, Inc. (NASDAQ:HSIC) on Wednesday, September 6.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>